Table of Content - Estrogen Blockers Market

Estrogen blockers are medicines that are used by FTM (female to male) individuals as part of their hormone replacement therapy (HRT) to suppress the effects of estrogen in the body. They can also help to promote the development of male secondary sexual characteristics. There are many different types of estrogen blockers available, and some are more effective than others.

Estrogen blockers can be taken in the form of tablets or injections. They are usually prescribed as part of a larger HRT treatment plan and are generally well tolerated by individuals who take them. For the most part, a hospital stay is not required when taking these medications, and they can often be given at home.

Market Dynamics

Estrogen blockers are largely used to treat hormone-related diseases like polycystic ovary syndrome (PCOS), endometriosis, and breast cancer. The demand for estrogen blockers rises as the prevalence of these illnesses rises internationally, fueling market expansion.

For instance, on June 28, 2023, according to a report published by the World Health Organization, reported that polycystic ovary syndrome (PCOS) is a significant public health problem and considered as one of the commonest hormonal disturbances affecting women of reproductive age. The condition affects an estimated 8–13% of women of reproductive age every year, and up to 70% of cases are undiagnosed.

On the other hand, like any drug, estrogen blockers have potential risks and adverse effects. Hot flashes, mood swings, joint discomfort, and increases in cholesterol levels are examples of typical side effects. In some circumstances, long-term use of estrogen blockers may raise the risk of cardiovascular issues and bone loss. Patients' compliance with and acceptance of estrogen blockers may be impacted by safety worries and possible side effects.

Key features of the study:

This report provides in-depth analysis of the global estrogen blockers market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global estrogen blockers market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Novartis AG, AstraZeneca PLC, Eli Lilly and Company, Merck & Co., Inc., Bristol Myers Squibb Company, Sanofi S.A., AbbVie Inc., GlaxoSmithKline plc, Olema Pharmaceuticals, Inc., Scorpion Therapeutics, Inc., Allorion Therapeutics Inc, Carrick Therapeutics Limited, Criterium, Inc. and Hoffmann-La Roche
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global estrogen blockers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global estrogen blockers market

Detailed Segmentation:

Global Estrogen Blockers Market, By Product Type:
- Selective Estrogen Receptor Modulators (SERMs)
- Aromatase Inhibitors
- Estrogen Receptor Downregulators (ERDs)
- Others
Global Estrogen Blockers Market, By Application:
- Breast Cancer Treatment
- Hormone Replacement Therapy (HRT)
- Infertility Treatment
- Post-Menopausal Osteoporosis
- Others
Global Estrogen Blockers Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Estrogen Blockers Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Estrogen Blockers Market, By Company:
- Pfizer Inc.
- Novartis AG
- AstraZeneca PLC
- Eli Lilly and Company
- Merck & Co., Inc.
- Bristol Myers Squibb Company
- Sanofi S.A.
- AbbVie Inc.
- GlaxoSmithKline plc
- Olema Pharmaceuticals, Inc.
- Scorpion Therapeutics, Inc.
- Allorion Therapeutics Inc
- Carrick Therapeutics Limited
- Criterium, Inc.
- F.Hoffmann-La Roche

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Estrogen Blockers, By Product Type
  - Market Estrogen Blockers, By Application
  - Market Estrogen Blockers, By Distribution Channel
  - Market Estrogen Blockers, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
    - Increasing Prevalence of Hormone-related Disorders
  - Restraints
    - Side Effects and Safety Concerns
  - Opportunities
    - Expansion of Indications
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
Global Estrogen Blockers Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
Global Estrogen Blockers Market , By Product Type, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 – 2030
  - Segment Trends
- Selective Estrogen Receptor Modulators (SERMs)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Aromatase Inhibitors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Estrogen Receptor Downregulators (ERDs)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Global Estrogen Blockers Market , By Application, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 – 2030
  - Segment Trends
- Breast Cancer Treatment
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Hormone Replacement Therapy (HRT)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Infertility Treatment
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Post-Menopausal Osteoporosis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Global Estrogen Blockers Market , By Distribution Channel, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 – 2030
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Global Estrogen Blockers Market , By Region, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, By Country, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, For Country 2019 –2030
  - Country Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
    - U.S.
    - Canada
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- AstraZeneca PLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Eli Lilly and Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bristol Myers Squibb Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sanofi S.A.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- GlaxoSmithKline plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Olema Pharmaceuticals, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Scorpion Therapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Allorion Therapeutics Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Carrick Therapeutics Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Criterium, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Hoffmann-La Roche
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Analyst Views
Section
- Research Methodology
- About us

*Browse 35 market data tables and 34 figures on "Global Estrogen Blockers Market” - Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount